2m 2m 2m 2m 2m 2m 2m
Aurinia Pharma (AUPH)
NASDAQ
$16.17+$0.07 (+0.45%)
Price as of Sep 11, 2026 7:55 PM EDT- $2.1BMarket Cap
- 26.37%1-Year Change
- BiotechnologyIndustry
Aurinia Pharma (AUPH)
$16.17+$0.07 (+0.45%)
AUPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.10 | ||
Change | -$0.010 (-0.06%) | ||
Open | $16.28 | ||
High | $16.35 | ||
Low | $16.05 | ||
Previous Close | $16.11 | ||
Volume | 745,441 | ||
30-Day Average Volume | 959,708 | ||
1-Week Change | 0.12% | ||
1-Month Change | 4.75% | ||
1-Year Change | 26.37% | ||
3-Year Change | 65.64% | ||
5-Year Change | -19.05% | ||
Fundamentals | |||
Shares Outstanding | 133.1M | ||
Total Assets | $792.3M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $79.4M | ||
Net Income | $37.4M | ||
Free Cash Flow | $52.6M | ||
EBIT | $48.8M | ||
EBITDA | $53.6M | ||
Net Working Capital | $441.4M | ||
EPS | $0.28 | ||
Enterprise Value/EBITDA | 37 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 3 | ||
P/E | 58 | ||
PEG | 5 | ||
Price/Free Cash Flow | 41 | ||
Price/Operating Cash Flow | 41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue